Hormonal receptor positive breast cancer adjuvant and metastatic indications
David Perez-Rey discusses his involvement with semantic interoperability and data model issues in the Personalized Medicine project, the main differences that the clinicians and patients will see when the project is finished and the challenges that they faced whilst creating it.
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
Multiple myeloma in a resource constrained setting
Synthetic biology and precision medicine in blood and gynaecological cancers
Early-stage breast cancer detection in breast milk
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Moving to the future: Artificial intelligence in surgery